Skip to content

rTMS Treatment in Vascular Parkinsonism

Effect of Repetitive Transcranial Magnetic Stimulation in Vascular Parkinsonism

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03720691
Acronym
rTMS
Enrollment
32
Registered
2018-10-25
Start date
2018-12-31
Completion date
2025-12-31
Last updated
2018-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Parkinsonism

Keywords

parkinsonism, vascular parkinsonism, repetitive transcranial magnetic stimulation, brain stimulation

Brief summary

Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was suggested in 1929. The main features are wide-based gait, postural instability, and falls, which make patients with VP frustrated. Currently, the treatment is challenging. Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively change brain activity to enhance desired effects. The aim of this study is to explore the therapeutic effect of rTMS for the VP.

Interventions

DEVICEReal rTMS Supplementary motor area

There will be a series of four rTMS blocks separated by 10 minutes. Each block will consist of 15 to 25 pulse trains of 1-second duration at 25 Hz, with an intertrain interval of 10 seconds.

DEVICESham rTMS Supplementary motor area

There will be no real brain stimulation in Sham rTMS, and participant will be blinded.

Sponsors

Dongtan Sacred Heart Hospital
CollaboratorOTHER
Inje University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Vascular parkinsonism * age 18 and older

Exclusion criteria

* pregnant or any, other medical, surgical, neurological or psychiatric conditions * other restrictions which prevent you from undergoing TMS recording, such as; surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), and/ or heart/cardiac lines * any past or current history of seizure disorder or epilepsy * unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Unified Parkinson's Disease Rating Scale (UPDRS) part III-motor part (Number 18 ~31 of UPDRS)2 daysMotor functions will be checked using UPDRS. Each item of the motor part ranges from 0 to 4 (0 means normal, 4 means worst condition). Total sum will be calculated.

Secondary

MeasureTime frameDescription
Finger tapping test with right hand2 daysFinger tapping test with right hand, as quickly as possible for 15 second. The total number of taps will be calculated. The test will be twice with one minute interval. After the test performed twice, the average of the tests will be used.
The total number of steps during the stand-walk-sit (SWS) test2 daysSWS test is Standing up, making a 9 m round trip, and sitting down as quickly as possible. The number of steps will be recorded.
The completion time during the SWS test2 daysThe completion time will be recorded.
Freezing episodes of gait trajectory2 daysThe number of freezing episodes during rapid full turns and dual task
Patient and Clinical Global Impression Scale2 days7-point scale that requires the patient (or clinician) to rate the response of the interventions. The rating will be numbered (1: very much improved; 2: much improved; 3: minimally improved; 4: no changes; 5: minimally worse; 6: much worse; 7: very much worse).

Countries

South Korea

Contacts

Primary ContactSang Jin Kim, MD, PhD
jsk120@hanmail.net82-51-890-8954

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026